Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with GSK2190915 on the allergen-induced asthmatic response in subjects with mild asthma
fiboflapon
LPA111834
NCT00748306
Asthma
Phase 2
 
November 2014

Powered by ideaPoint, Inc.